8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
1982 / Interventional experimental absorption study
Approximately 60% of an oral dose of 100 micrograms of 203Pb was retained in 85 fasting subjects, with no sex differences and proportional retention up to 400 micrograms. Lead retention was not related to iron absorption capacity or iron stores, nor altered by a 10-fold molar excess of iron, zinc, cobalt, or calcium, or lactose. Eating food lowered lead retention, fat slightly increased it, ascorbic acid slightly reduced it, and ethylenediaminetetraacetic acid markedly reduced it.
Flanagan PR, Chamberlain MJ, Valberg LS Am J Clin Nutr, 1982. PMID 6814228
1982 / Uncontrolled clinical trial
One hundred seventy-eight cancer patients received amygdalin alongside a metabolic regimen of diet, enzymes, and vitamins. The treatment produced no measurable cure, tumor stabilization, symptom relief, or prolonged survival. Several participants experienced manifestations of cyanide toxicity, with blood cyanide concentrations nearing fatal thresholds.
Moertel CG, Fleming TR, Rubin J, et al. N Engl J Med, 1982. PMID 7033783
1977 / Oral provocation trial
Fourteen asthma patients who reported exacerbations after consuming orange drinks were tested with solutions of sulphur dioxide, sodium benzoate, and tartrazine on separate occasions. Eight patients reacted to sulphur dioxide with a fall in FEV1, four reacted to sodium benzoate, one reacted to tartrazine, and four did not react to any agent (three benzoate-sensitive patients were also sensitive to sulphur dioxide). Prior inhalation of sodium cromoglycate inhibited the reactions in four tested patients.
Freedman BJ Clin Allergy, 1977. PMID 412611
1976 / Metabolic tracer kinetic study
Five healthy men living in a metabolic unit on constant low-lead diets were supplemented daily with 79-204 mug of enriched lead-204 as nitrate ingested with meals for 1-124 days. Serial measurements of lead concentration and isotopic composition suggested a three-compartment model of lead metabolism. The first compartment encompasses blood (1.5-2.2 times blood mass), contains about 1.7-2.0 mg of lead, and has a mean life of 35 days. The second compartment is mainly soft tissue, contains about 0.3-0.9 mg of lead, has a mean life of approximately 40 days, and supplies lead to hair, nails, sweat, and alimentary tract secretions. The third compartment resides primarily in the skeleton, contains the vast quantity of body lead, and has a very slow mean life.
Rabinowitz MB, Wetherill GW, Kopple JD J Clin Invest, 1976. PMID 783195
1972 / Experimental metabolism study (ex vivo and in vivo)
Tissues and gut contents from animals and a human converter were incubated with [14C]cyclamate to assess its metabolism. Cyclamate was not metabolized by liver, spleen, kidney, or blood, but was converted into cyclohexylamine under anaerobic conditions by caecal, colonic, or rectal contents and faeces from pretreated rats, rabbits, and a human converter. Faeces from the human converter lost activity when cyclamate was removed from the diet. The gut organisms developing the ability to convert cyclamate appear to be clostridia in rats, enterobacteria in rabbits, and enterococci in humans.
Drasar BS, Renwick AG, Williams RT Biochem J, 1972. PMID 4655823